Nayak Sanjayinsider trades
In SEC Form 4 filings, Nayak Sanjay is listed as Chief Strategy Officer of Ocular Therapeutix, Inc (OCUL). In the last 90 days, Nayak Sanjay sold $20.4K of Ocular Therapeutix, Inc (OCUL) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| OCULOcular Therapeutix, Inc | Chief Strategy Officer | 1 | Aug 26 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-26
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.